"Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications. Issue 4 (9th March 2022)

• Record Type: Journal Article
• Authors: Marchetti, Bianca; Giachino, Carmela; Tirolo, Cataldo; Serapide, Maria F.
• Is Part Of: Aging cell. Volume 21:Issue 4(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-03-09
• Subjects: dopamine signaling -- glial–neuron crosstalk -- inflammation -- Nrf2/Wnt signaling -- oxidative stress -- Parkinson's disease; Cells -- Aging -- Periodicals; 571.8783605
• DOI: 10.1111/acel.13575
• Languages: English
• ISSNs: 1474-9718

Abstract

Abstract: Dopamine (DA) signaling via G protein‐coupled receptors is a multifunctional neurotransmitter and neuroendocrine–immune modulator. The DA nigrostriatal pathway, which controls the motor coordination, progressively degenerates in Parkinson's disease (PD), a most common neurodegenerative disorder (ND) characterized by a selective, age‐dependent loss of substantia nigra pars compacta (SNpc) neurons, where DA itself is a primary source of oxidative stress and mitochondrial impairment, intersecting astrocyte and microglial inflammatory networks. Importantly, glia acts as a preferential neuroendocrine–immune DA target, in turn, counter‐modulating inflammatory processes. With a major focus on DA intersection within the astrocyte–microglial inflammatory network in PD vulnerability, we herein first summarize the characteristics of DA signaling systems, the propensity of DA neurons to oxidative stress, and glial inflammatory triggers dictating the vulnerability to PD. Reciprocally, DA modulation of astrocytes and microglial reactivity, coupled to the synergic impact of gene–environment interactions, then constitute a further level of control regulating midbrain DA neuron (mDAn) survival/death. Not surprisingly, within this circuitry, DA converges to modulate nuclear factor erythroid 2 ‐ like 2 (Nrf2), the master regulator of cellular defense against oxidative stress and inflammation, and Wingless ( Wnt )/ β ‐ catenin signaling, a key pathway for mDAn neurogenesis, neuroprotection, and immunomodulation, adding to the already complex "signaling puzzle, " a novel actor in mDAn–glial regulatory machinery. Here, we propose an autoregulatory feedback system allowing DA to act as an endogenous Nrf2 / Wnt innate modulator and trace the importance of DA receptor agonists applied to the clinic as immune modifiers. Abstract : Besides its central role as neurotransmitter and neuroendocrine–immune modulator, we herein propose DA acting as endogenous Nrf2/Wnt innate modulator intersecting astrocyte–microglial inflammatory networks in PD vulnerability. With age and PD, the dramatic loss of DA‐mediated signaling at central and peripheral levels drives interacting harmful cascades whereby loss of DA/Nrf2/Wnt‐resilient signaling engenders a detrimental vicious cycle, further aggravating inflammation with severe outcome.